Role of probiotics in treatment of nonalcoholic fatty liver disease
10.3760/cma.j.issn.1007-3418.2017.01.022
- VernacularTitle: 益生菌在非酒精性脂肪肝治疗中的作用
- Author:
Mo CHEN
1
,
2
;
Mancai WANG
1
,
2
;
Rui NI
1
,
2
;
Jun WANG
1
;
Liang WANG
1
,
2
;
Gennian WANG
1
,
2
;
Lingyi ZHANG
1
,
3
Author Information
1. Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China
2. Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China
3. Department of Hepatology, Lanzhou University Second Hospital, Lanzhou 730030, China
- Publication Type:Review
- Keywords:
Probiotics;
Nonalcoholic fatty liver disease;
Intestinal flora
- From:
Chinese Journal of Hepatology
2017;25(1):77-80
- CountryChina
- Language:Chinese
-
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases in China and manifests as simple fatty liver, non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. Studies have shown that intestinal flora can affect the development and progression of NAFLD via the "gut-liver axis" . Probiotics are active microorganisms with beneficial effects on the host, and more and more studies have found that probiotics play a positive role in improving NAFLD. They are cheaper, less harmful, and safer compared with antibiotics and surgery, and therefore, it may become a new method for the prevention and treatment of NAFLD. This article reviews the research advances in probiotics in the treatment of NAFLD, in order to provide a basis for the treatment of NAFLD using probiotics.
